September 1, 2003Seminars in Cardiothoracic and Vascular Anesthesia
Evolving Strategies for the Prevention and Treatment of Coronary Restenosis
Key result
Emerging strategies like radiation and gene therapy aim to prevent and treat coronary restenosis.
Why the study?
Restenosis after percutaneous coronary intervention remains a significant clinical problem despite advances such as intracoronary stents, necessitating evaluation of emerging prevention and treatment strategies.
Population
Patients undergoing percutaneous coronary intervention
Comparison
Various strategies for prevention and treatment of coronary restenosis including stents, radiation, immunosuppressive agents, gene therapy
Design
Review article
Authors
Discussion
Loading...
Member takes
Implication
Restenosis limits PCI durability; leaves open effective prevention strategies for practice and targeted trials.
Structured PICO
P
Population
Patients undergoing percutaneous coronary intervention
I
Intervention
Various strategies for the prevention and treatment of coronary restenosis (including intracoronary stents, local delivery of ionizing radiation, immunosuppressive agents, and gene therapy)
O
Outcome
Coronary restenosis
This review summarizes the evolution of strategies to prevent and treat coronary restenosis, highlighting the shift from systemic pharmacologic agents to localized mechanical, radiation-based, and biological therapies.
Cite This Study
Dee et al. (2003) conducted a review in Coronary Restenosis. Emerging strategies for restenosis was evaluated. Emerging strategies such as ionizing radiation, immunosuppressive agents, and gene therapy are being deployed to prevent and treat coronary restenosis, which occurs at rates of 20% to 40%.